Literature DB >> 31686003

The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.

Gerta Hoxhaj1,2, Brendan D Manning3.   

Abstract

The altered metabolic programme of cancer cells facilitates their cell-autonomous proliferation and survival. In normal cells, signal transduction pathways control core cellular functions, including metabolism, to couple the signals from exogenous growth factors, cytokines or hormones to adaptive changes in cell physiology. The ubiquitous, growth factor-regulated phosphoinositide 3-kinase (PI3K)-AKT signalling network has diverse downstream effects on cellular metabolism, through either direct regulation of nutrient transporters and metabolic enzymes or the control of transcription factors that regulate the expression of key components of metabolic pathways. Aberrant activation of this signalling network is one of the most frequent events in human cancer and serves to disconnect the control of cell growth, survival and metabolism from exogenous growth stimuli. Here we discuss our current understanding of the molecular events controlling cellular metabolism downstream of PI3K and AKT and of how these events couple two major hallmarks of cancer: growth factor independence through oncogenic signalling and metabolic reprogramming to support cell survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31686003      PMCID: PMC7314312          DOI: 10.1038/s41568-019-0216-7

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  322 in total

1.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 2.  Implications of cellular metabolism for immune cell migration.

Authors:  Hannah Guak; Connie M Krawczyk
Journal:  Immunology       Date:  2020-09-29       Impact factor: 7.397

3.  Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.

Authors:  Junmei Yi; Jiajun Zhu; Jiao Wu; Craig B Thompson; Xuejun Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 4.  Metabolic pathways in obesity-related breast cancer.

Authors:  Kristy A Brown
Journal:  Nat Rev Endocrinol       Date:  2021-04-29       Impact factor: 43.330

5.  Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway.

Authors:  Wei Zhang; Ankur S Bhagwath; Zeeshan Ramzan; Taylor A Williams; Indhumathy Subramaniyan; Vindhya Edpuganti; Raja Reddy Kallem; Kerry B Dunbar; Peiguo Ding; Ke Gong; Samuel A Geurkink; Muhammad S Beg; James Kim; Qiuyang Zhang; Amyn A Habib; Sung-Hee Choi; Ritu Lapsiwala; Gayathri Bhagwath; Jonathan E Dowell; Shelby D Melton; Chunfa Jie; William C Putnam; Thai H Pham; David H Wang
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.261

6.  Hetero-oligomerization of Rho and Ras GTPases Connects GPCR Activation to mTORC2-AKT Signaling.

Authors:  Hiroshi Senoo; May Wai; Hideaki T Matsubayashi; Hiromi Sesaki; Miho Iijima
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

Review 7.  Ras, PI3K and mTORC2 - three's a crowd?

Authors:  Stephen F Smith; Shannon E Collins; Pascale G Charest
Journal:  J Cell Sci       Date:  2020-10-08       Impact factor: 5.285

8.  Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition.

Authors:  Liang Yan; Bo Tu; Jun Yao; Jing Gong; Alessandro Carugo; Christopher A Bristow; Qiuyun Wang; Cihui Zhu; Bingbing Dai; Ya'an Kang; Leng Han; Ningping Feng; Yanqing Jin; Jason Fleming; Timothy P Heffernan; Wantong Yao; Haoqiang Ying
Journal:  Cancer Res       Date:  2021-06-11       Impact factor: 12.701

9.  The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells.

Authors:  Inah Camaya; Tsz Y Mok; Maria Lund; Joyce To; Nady Braidy; Mark W Robinson; Jerran Santos; Bronwyn O'Brien; Sheila Donnelly
Journal:  J Mol Med (Berl)       Date:  2021-08-10       Impact factor: 4.599

10.  LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.

Authors:  Doumet Georges Helou; Pedram Shafiei-Jahani; Benjamin P Hurrell; Jacob D Painter; Christine Quach; Emily Howard; Omid Akbari
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.